0000784199-16-000297.txt : 20160914
0000784199-16-000297.hdr.sgml : 20160914
20160914174559
ACCESSION NUMBER: 0000784199-16-000297
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160906
FILED AS OF DATE: 20160914
DATE AS OF CHANGE: 20160914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRYOLIFE INC
CENTRAL INDEX KEY: 0000784199
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 592417093
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
BUSINESS PHONE: 7704193355
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McDermid James M
CENTRAL INDEX KEY: 0001681601
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13165
FILM NUMBER: 161885906
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BLVD NW
CITY: KENNESAW
STATE: GA
ZIP: 30144
3
1
certent-form3.xml
PRIMARY DOCUMENT
X0206
3
2016-09-06
0
0000784199
CRYOLIFE INC
CRY
0001681601
McDermid James M
1655 ROBERTS BLVD NW
KENNESAW
GA
30144
0
1
0
0
SVP, CHRO
Common Stock
3396
D
Stock Option
17.24
2017-09-09
2023-09-09
Common Stock
3396
D
Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company.
Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date.
/s/ J McDermid
2016-09-14
EX-24
2
poamcdermid.txt
Exhibit 24
CONFIRMING STATEMENT
This Statement confirms that the undersigned has authorized and designated
the Chief Executive Officer, Chief Financial Officer, or the Corporate
Secretary of CryoLife, Inc. to execute and file on the undersigned's behalf
all Forms 3, 4 and 5 (including any amendments thereto) that the
undersigned may be required to file with the U.S. Securities and Exchange
commission as a result of the undersigned's ownership of or transactions
in securities of CryoLife, Inc. The authority of the Chief Executive
Officer, Chief Financial Officer, or the Corporate Secretary of CryoLife,
Inc. under this Statement shall continue until the undersigned is no longer
required to file Forms 3, 4 and 5 with regard to the undersigned's
ownership of or transactions in securities of CryoLife, Inc., unless
earlier revoked in writing. The undersigned acknowledges that the Chief
Executive Officer, Chief Financial Officer, or the Corporate Secretary of
CryoLife, Inc. is not assuming any of the undersigned's responsibilities
to comply with Section 16 of the Securities Exchange Act of 1934.
Dated as of September 13, 2016 /s/ James McDermid
James McDermid